|
|
||||||||
Howard Hughes Medical Institute, Department of Chemistry and Biochemistry, University of Colorado at Boulder, Boulder, Colorado 80309-0215, USA
Reprint requests to: Thomas R. Cech, Howard Hughes Medical Institute, Department of Chemistry and Biochemistry, University of Colorado, Boulder, CO 80309-0215, USA; e-mail: Thomas.Cech{at}colorado.edu; fax: (303) 492-6194.
(RECEIVED April 21, 2005; FINAL REVISION May 20, 2005; ACCEPTED May 20, 2005)
| Abstract |
|---|
|
|
|---|
Keywords: telomerase; GFP; high throughput; TERT
Article and publication are at http://www.proteinscience.org/cgi/doi/10.1110/ps.051532105.
| Introduction |
|---|
|
|
|---|
The functions of these N-terminal regions have recently begun to be explored. The results of several studies suggest that the QFP, CP, and T motifs (Fig. 1
) of TERT homologs from Tetrahymena thermophila, Saccharomyces cerevisiae, and humans are necessary for specific interaction with the telomerase RNA subunit (Friedman and Cech 1999; Bryan et al. 2000b; Armbruster et al. 2001; OConnor et al. 2005). Several functions have been proposed for the conserved region present near the N terminus of TERT, called the GQ motif (Xia et al. 2000), including recruitment of a telomerase regulatory protein Est3p and nonspecific nucleic acid binding in budding yeast (Xia et al. 2000; Friedman et al. 2003), interactions with telomeric DNA and telomerase RNA in humans (Lee et al. 2003; Moriarty et al. 2004), and interactions with telomerase RNA in T. thermophila (OConnor et al. 2005). Despite these recent advances by functional studies, knowledge of the boundaries of the true structured domains of the TERT protein remains elusive.
|
| Results |
|---|
|
|
|---|
In order to circumvent these problems, we employed high-throughput screening of random fragments of the T. thermophila TERT protein using a GFP-fusion solubility reporter (Waldo et al. 1999; Kawasaki and Inagaki 2001). Random fragments of the TERT gene of size 6003400 base pairs were generated by random-tagged PCR (Grothues et al. 1993) and inserted into the pProGFP expression vector upstream of the GFP gene (Kawasaki and Inagaki 2001). E. coli colonies overexpressing soluble TERT-GFP fusion proteins are expected to display strong GFP fluorescence when a standard agar plate is illuminated with a 366 nm UV lamp. Although only 1 in 18 colonies are expected to express the GFP-fusion protein in frame, this method allows for the examination of thousands of constructs in only a few days. An additional advantage of this high-throughput system is that soluble expression of TERT-GFP fusion proteins is monitored in vivo, thus avoiding the laborious steps needed to separate and analyze insoluble and soluble fractions of each construct, as is required of other high-throughput systems (Knaust and Nordlund 2001).
Figure 2A
shows an example of E. coli colonies expressing the TERT-GFP fusion library after irradiation with UV light. From this library, fluorescent colonies were selected for expression tests as shown in Figure 2, B and C
. Colonies 110 represent a subset of the brightly fluorescent colonies obtained, while colony 11 represents a nonfluorescent control colony. Approximately 10,000 colonies were screened, and ~1.0% showed a strong fluorescence signal. Colonies displaying a strong fluorescent signal were selected for expression tests in 24-well tissue culture plates in 0.5-mL cultures. Addition of IPTG to the cultures resulted in the clear overexpression of fusion proteins for most fluorescent colonies as visualized by SDS-PAGE analysis (Fig. 2C
). We found that approximately 1 in 15 fluorescent colonies did not result in the clear overexpression of a fusion protein, perhaps due to post-translational degradation of the fusion protein or the exposure of an internal cryptic ribosome-binding site within the TERT sequence.
|
|
It is conceivable that the random fragment screen might produce protein constructs that are soluble but aremade up of multiple structured domains or that are not folded. To address these concerns, we subjected TERT-GQ to limited proteolysis by Lys-C and analyzed the products by SDS-PAGE (Fig. 3
). Lys-C digestion produced two fragments of approximately 20 kDa with only the smaller being stable at high Lys-C concentrations (Fig. 3
, cf. lanes 2 and 3). MALDI mass spectrometry analysis showed that there were actually four stable species present after digestion with Lys-C having masses of 21,378, 21,256, 20,461, and 20,332 kDa. The masses correspond to protein fragments consisting of amino acids 4185, 4184, 13185, and 13 184, respectively. Notably, K18 and K182 are protected from proteolysis by Lys-C under our experimental conditions, suggesting that the boundaries for a folded region of this polypeptide lie between residues 13 and 18 at the N terminus and either residue 183 or 184 at the C terminus.
|
|
GQ) was tested for catalytic activity in order to determine if TERT-GQ is an essential protein domain. Full-length TERT or TERT
GQ was expressed in vitro in rabbit reticulocyte lysates in the presence of in vitro transcribed telomerase RNA and assayed for the ability to extend the telomeric oligonucleotide (TTGGGG)3. As seen in Figure 5
GQ. Thus, we conclude that the TERT-GQ domain is essential for telomerase activity in vitro.
|
| Discussion |
|---|
|
|
|---|
Our demonstration that the GQ motif is part of a protein domain not dependent upon further C-terminal sequences for folding is consistent with previous studies on the human homolog. In these experiments, it was demonstrated that production of TERT fragments containing the GQ motif in trans with a GQ deletion mutant can rescue TERT activity when TERT is assembled in the rabbit reticulate lysate in vitro transcription/translation system (Beattie et al. 2001; Moriarty et al. 2004).
In this report, we have provided a map of regions of the T. thermophila TERT protein that can be highly overexpressed and purified to homogeneity from E. coli using the GFP-fusion solubility reporter as a high-throughput tool. This powerful technique, which combines the generation of random protein fragments with the GFP-fusion solubility reporter (Waldo et al. 1999), has to our knowledge been applied to only one other protein sequence, the mouse Vav protein (Kawasaki and Inagaki 2001). The random nature of the protein constructs generated during the screening is particularly suited for a protein like TERT that has only limited sequence similarity among family members, because it generates protein constructs for expression that are unbiased by weak multiple sequence alignments or limited biochemical data. The results of this screen will provide a tool for future structural and biochemical analysis of the TERT protein.
| Materials and methods |
|---|
|
|
|---|
Protein expression and purification
TERT-GQ (residues 2191) was subcloned into the NdeI and BamHI sites of pET11a using the primer pair ggaattccatatgaaaaaacaccatcaccatcaccatcagaaaattaacaacatt and cgggatccttagttgtttttataccattt. The first primer builds the sequence MKK HHHHHH into the N terminus of the protein sequence to aid in purification. TERT-GQ2 (residues 13184) was subcloned into the NdeI and BamHI sites of pET28a using the oligos ggaattccatatgctgacccgcaaa and cgggatccttatttctgtttcacctggac. All protein constructs were expressed in E. coli BL21(DE3) (Stratagene) by growing the cells at 37°C to an OD600 of 0.6, after which IPTG was added to 0.1 mM and the temperature dropped to 18°C. Cells were harvested by centrifugation 18 h after induction. Cell pellets were resuspended in buffer A (50 mM sodium phosphate [pH 8.0], 500 mM NaCl, 10 mM imidazole, 10% glycerol, 1 mM PMSF, 5 mM
-mercaptoethanol) with 0.1 mg/mL lysozyme and lysed by brief sonication. Cleared lysates were passed over a 5 mL Ni-NTA resin and washed with 200 mL of Buffer A. Bound proteins were eluted in 50mM sodium phosphate (pH 8.0), 250 mMNaCl, 250 mM imidazole, and 10% glycerol (Buffer B).
TERT-GQ was further purified by a Sephadex-SP cation exchange column (Amersham Biosciences) in a buffer of 20 mM MES (pH 6.0) with a gradient of NaCl from 0 to 1.0 M. TERT-GQ typically eluted at a NaCl concentration of 750 mM. Fractions from the SP column were pooled and concentrated in a spin concentrator (Millipore) and further purified on a Superdex 75 gel filtration column (Amersham Biosciences) in 20 mM MES (pH 6.0), 250 mM NaCl.
TERT-GQ2 was purified by Ni-NTA affinity chromatography as described above for TERT-GQ. Fractions from the Ni- NTA column were treated with 100 U of thrombin (Amersham Biosciences) in order to cleave the histidine tag and dialyzed against 1 L of a solution of 50 mM sodium phosphate (pH 8.0), 150 mM NaCl, 2 mM DTT at 4°C for 18 h. Uncut product and thrombin were removed by Ni-NTA (Qiagen) and Benzamadine sepharose (Amersham Biosciences) chromatography. Final purification was performed on a Superdex 75 gel filtration column in 50 mM HEPES (pH 7.5), 150 mM NaCl, and 1 mM DTT.
15N-labeled TERT-GQ2 was prepared as above except that the protein was expressed in minimal media supplemented with (15NH4)2SO4 (1.5 g/L) (Aldrich).
Limited proteolysis
TERT-GQ was concentrated to 10 mg/mL and dialyzed extensively against water to remove all buffers and salts to aid in downstream mass spectrometry analysis. For digestion, 20 or 2 ng of Lys-C enzyme (Promega) was added to 10 µL of the protein solution and incubated at 37°C for 3 h. Following digestion, products were analyzed by 4%12% SDS-PAGE (Invitrogen) or MALDI mass spectometry using a Voyager- DE STR mass spectrometer (PerSeptive Biosystems).
NMR spectroscopy
NMR data were collected on a Varian INOVA 500MHz spectrometer equipped with a Nalorac HCN triple resonance Z-gradient probe on 15N-labeled 800 µM TERT-GQ2 samples in 20 mM MES (pH 6.5), 25 mMNaCl, 1 mMDTT, 5%D2O at 30°C. Varian BioPack pulse sequences were used with minor modifications. Spectra were processed using NMRPipe (Delaglio et al. 1995) and analyzed with NMR View (Johnson and Blevins 1994).
Telomerase activity assay
Gene sequences for TERT (Bryan et al. 2000a) and TERT
GQ (residues 1921117) were subcloned into pET28a and expressed in the TNT rabbit reticulocyte lysate system (Promega) in 250 µL volume with 2.5 µg of plasmid DNA, 200 µL TNT Quick Master mix, 10 µL PCR enhancer, 5 pmol in vitro transcribed telomerase RNA (Bryan et al. 2000a), 10 µM 35S-methionine (10 mCi/mL), and 20 µM cold methionine, and incubated at 30°C for 3 h. The telomerase complex was pulled down by incubating the reaction with 100 µL of T7-tag antibody agarose beads (Novagen) for 1 h at 4°C and washing three times with wash buffer included in the T7-tag antibody agarose bead kit and then three times in telomerase activity buffer composed of 50 mM Tris-HCl (pH 8.3), 1.25 mM MgCl2, 5 mM DTT, and 30% glycerol before being stored at 20°C; 2 µL of each pull-down reaction were examined for protein content by running on a 4%12% Bis-Tris (Novagen) SDS-PAGE gel.
Activity assays were performed by incubating 10 µL of T7 pull-down beads in 20 µL of 1 µM DNA oligo (TTGGGG)3, 50 mM Tris-HCl (pH 8.3), 1.25 mM MgCl2, 5 mM DTT, 30% glycerol, 0.1 mM dTTP, 8.75 µM dGTP, 1.25 µM
32P-dGTP for 1 h at 30°C. Reactions were stopped by adding 100 µL of stop solution containing 3.6 M ammonium acetate, 1 mg/mL glycogen and a 32P-labeled 100mer DNA oligo that acts as a loading control. DNA products were ethanol precipitated and run out on a 10% polyacrylamide, 7 M urea, 1x TBE sequencing gel for analysis.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
Bachand, F. and Autexier, C. 1999. Functional reconstitution of human telomerase expressed in Saccharomyces cerevisiae. J. Biol. Chem. 274: 3802738031.
Beattie, T.L., Zhou, W., Robinson, M.O., and Harrington, L. 2001. Functional multimerization of the human telomerase reverse transcriptase. Mol. Cell. Biol. 21: 61516160.
Bryan, T.M., Goodrich, K.J., and Cech, T.R. 2000a. A mutant of Tetrahymena telomerase reverse transcriptase with increased processivity. J. Biol. Chem. 275: 2419924207.
. 2000b. Telomerase RNA bound by protein motifs specific to telomerase reverse transcriptase. Mol. Cell. 6: 493499.[CrossRef][Medline]
Chenna, R., Sugawara, H., Koike, T., Lopez, R., Gibson, T.J., Higgins, D.G., and Thompson, J.D. 2003. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res. 31: 34973500.
Delaglio, F., Grzesiek, S., Vuister, G.W., Zhu, G., Pfeifer, J., and Bax, A. 1995. NMRPipe: A multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6: 277293.[Medline]
Friedman, K.L. and Cech, T.R. 1999. Essential functions of amino-terminal domains in the yeast telomerase catalytic subunit revealed by selection for viable mutants. Genes & Dev. 13: 28632874.
Friedman, K.L., Heit, J.J., Long, D.M., and Cech, T.R. 2003. N-terminal domain of yeast telomerase reverse transcriptase: Recruitment of Est3p to the telomerase complex. Mol. Biol. Cell 14: 113.
Greider, C.W. and Blackburn, E.H. 1989. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 337: 331337.[CrossRef][Medline]
Grothues, D., Cantor, C.R., and Smith, C.L. 1993. PCR amplification of megabase DNA with tagged random primers (T-PCR). Nucleic Acids Res. 21: 13211322.
Johnson, B.A. and Blevins, R.A. 1994. NMRview: A computer program for the visualization and analysis of NMR data. J. Biomol. NMR 4: 603614.[CrossRef]
Kawasaki, M. and Inagaki, F. 2001. Random PCR-based screening for soluble domains using green fluorescent protein. Biochem. Biophys. Res. Commun. 280: 842844.[CrossRef][Medline]
Kelleher, C., Teixeira, M.T., Forstemann, K., and Lingner, J. 2002. Telomerase: Biochemical considerations for enzyme and substrate. Trends Biochem. Sci. 27: 572579.[CrossRef][Medline]
Knaust, R.K. and Nordlund, P. 2001. Screening for soluble expression of recombinant proteins in a 96-well format. Anal. Biochem. 297: 7985.[CrossRef][Medline]
Lee, S.R., Wong, J.M., and Collins, K. 2003. Human telomerase reverse transcriptase motifs required for elongation of a telomeric substrate. J. Biol. Chem. 278: 5253152536.
Lingner, J., Hughes, T.R., Shevchenko, A., Mann, M., Lundblad, V., and Cech, T.R. 1997. Reverse transcriptase motifs in the catalytic subunit of telomerase. Science 276: 561567.
Masutomi, K., Kaneko, S., Hayashi, N., Yamashita, T., Shirota, Y., Kobayashi, K., and Murakami, S. 2000. Telomerase activity reconstituted in vitro with purified human telomerase reverse transcriptase and human telomerase RNA component. J. Biol. Chem. 275: 2256822573.
Mikuni, O., Trager, J.B., Ackerly,H.,Weinrich, S.L., Asai, A., Yamashita, Y., Mizukami, T., and Anazawa, H. 2002. Reconstitution of telomerase activity utilizing human catalytic subunit expressed in insect cells. Biochem. Biophys. Res. Commun. 298: 144150.[CrossRef][Medline]
Moriarty, T.J., Marie-Egyptienne, D.T., and Autexier, C. 2004. Functional organization of repeat addition processivity and DNA synthesis determinants in the human telomerase multimer. Mol. Cell. Biol. 24: 37203733.
OConnor, C.M., Lai, C.K., and Collins, K. 2005. Two purified domains of telomerase reverse transcriptase reconstitute sequence-specific interactions with RNA. J. Biol. Chem. 17: 1753317539.
Schnapp, G., Rodi, H.P., Rettig, W.J., Schnapp, A., and Damm, K. 1998. One-step affinity purification protocol for human telomerase. Nucleic Acids Res. 26: 33113313.
Sousa, R. 1996. Structural and mechanistic relationships between nucleic acid polymerases. Trends Biochem. Sci. 21: 186190.[CrossRef][Medline]
Waldo, G.S., Standish, B.M., Berendzen, J., and Terwilliger, T.C. 1999. Rapid protein-folding assay using green fluorescent protein. Nat. Biotechnol. 17: 691695.[CrossRef][Medline]
Weinrich, S.L., Pruzan, R., Ma, L., Ouellette, M., Tesmer, V.M., Holt, S.E., Bodnar, A.G., Lichtsteiner, S., Kim, N.W., Trager, J.B., et al. 1997. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat. Genet. 17: 498502.[CrossRef][Medline]
Xia, J., Peng, Y., Mian, I.S., and Lue, N.F. 2000. Identification of functionally important domains in the N-terminal region of telomerase reverse transcriptase. Mol. Cell. Biol. 20: 51965207.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. R. Dyson, R. L. Perera, S. P. Shadbolt, L. Biderman, K. Bromek, N. V. Murzina, and J. McCafferty Identification of soluble protein fragments by gene fragmentation and genetic selection Nucleic Acids Res., May 1, 2008; 36(9): e51 - e51. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Finger and T. M. Bryan Multiple DNA-binding sites in Tetrahymena telomerase Nucleic Acids Res., March 27, 2008; 36(4): 1260 - 1272. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Rossignol, S. Collier, M. Bush, P. Shaw, and J. H. Doonan Arabidopsis POT1A interacts with TERT-V(I8), an N-terminal splicing variant of telomerase J. Cell Sci., October 15, 2007; 120(20): 3678 - 3687. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Romi, N. Baran, M. Gantman, M. Shmoish, B. Min, K. Collins, and H. Manor High-resolution physical and functional mapping of the template adjacent DNA binding site in catalytically active telomerase PNAS, May 22, 2007; 104(21): 8791 - 8796. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Terribilini, J.-H. Lee, C. Yan, R. L. Jernigan, V. Honavar, and D. Dobbs Prediction of RNA binding sites in proteins from amino acid sequence RNA, August 1, 2006; 12(8): 1450 - 1462. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |